"Lessons for Britain from India's 'Vaccine Prince'"

Adar Poonawalla, CEO of Serum Institute of India, emphasizes the importance of investing in vaccine manufacturing facilities to prepare for future pandemics, warning that political will is fading post-Covid. The institute, known as the "pharmacy of the world," is expanding its focus to prepare for potential future pandemics, with a two-pronged approach involving stockpiling and rapid manufacturing capabilities. While efforts in Europe to enhance vaccine manufacturing capacity are proactive, the UK is criticized for its lack of political interest in this area. Poonawalla stresses the need for diverse global manufacturing capabilities to avoid supply-chain issues and ensure equitable access to vaccines, emphasizing the commitment to fair distribution and global health equity.